Preventing HIV infection in women, including those who are pregnant or breastfeeding, is the most efficient way to avoid HIV infections in infants—and it saves women’s lives as well. Programs and policy makers can give attention to strengthening primary prevention services, such as counseling and testing, and condom provision to reduce the risk of sexual HIV transmission. Providers can counsel couples on reducing their risk of acquiring HIV and other STIs, offer condoms as needed, and promote HIV testing and counseling for pregnant and postpartum women including retesting, couples counseling.
Preventing Unintended Pregnancies
Family planning provides couples with HIV an opportunity to prevent unintended pregnancies and to avoid having children who are infected with HIV. Strengthening family planning programs for all women, especially in high prevalence settings, will reach many infected women who still do not know their status and need family planning. Providers can help women who want to avoid pregnancy choose and use a family planning method effectively.
In this issue of HIV and AIDS Treatment in Practice (HATiP) pillar two, the prevention of unintended pregnancies in women living with HIV, is the focus. The author reviews integratin of HIV and family planning programs as well as provides examples of best practice, practical suggestions from clinicians in the field as well as relevant tools and resources for resource-poor settings relatd to the preveniton of unintended pregnancies in women with HIV.
With access to family planning services, supportive care, and the information needed to make good choices, women with human immunodeficiency virus (HIV), including women with acquired immune deficiency syndrome (AIDS), in many cases can lead healthy sexual and reproductive lives. Like all other women, women with HIV have the right to make their own decisions about their reproductive and sexual health. Health care programs and providers can help women with HIV and their partners make and carry out informed reproductive health decisions.
Most efforts to reduce mother-to-child transmission of HIV focus on increasing HIV counseling and testing services and services that provide antiretroviral drugs, like nevirapine, to HIV-infected mothers and their newborns. But another strategy is to increase contraceptive use among sexually active women who wish to avoid pregnancy. Family Health International has developed a model to assess the cost-effectiveness of this strategy—preventing unintended pregnancies—as an HIV prevention approach.
The risk that a woman with HIV will transmit the virus to her infant can be reduced in a number of ways—prophylaxis with ARVs during pregnancy and breastfeeding, cesarean-section delivery, and following safe infant feeding practices. For more information on the most current WHO guidelines and recommendations for preventing vertical transmission of HIV go to the Policy and Guidelines section of the toolkit.
In late 2009, WHO convened a series of technical consultations to update recommendations for treatment, prevention and infant feeding in the context of HIV. Based on the latest scientific evidence, these guidelines reflect continual progress in our knowledge of effective treatment and standards of care for persons infected with HIV. Officially released in July 2010, the recommendations have for the first time been organized as a set of linked guidelines for adult, adolescent and pediatric treatment, PMTCT and infant and young child feeding.
In late 2009, the WHO released preliminary updated recommendations for treatment, prevention and infant feeding in the context of HIV. Based on the latest scientific evidence, these guidelines represent the continual progress in our knowledge of effective treatment and standards of care for persons infected with HIV. Officially released in July 2010, the recommendations have for the first time been organized as a set of linked guidelines for treatment of for adult, adolescent and pediatric treatment, PMTCT,
This presentation was given at Expert Panel on Prevention of Mother-to-Child Transmission of HIV given through PEPFAR (U.S. President's Emergency Plan for AIDS Relief). Presentation points out that because of a cascade effect, significantly increasing the coverage of existing treatment delivery systems by ensuring that women who attend an antenatal clinic also receive HIV testing and antiretroviral treatment could be as, or more effective than use of better PMTCT regimens. Dr.
Despite the potential of PCR methodologies, their costs remain prohibitive for resource-poor countries. Further reduction in the costs of PCR technology, corporate programs for donation of supplies and equipment, and the transfer of intellectual property rights to generic manufacturers (as has occurred with patented drugs) would greatly facilitate implementation of low-cost early diagnosis of HIV infection in infants.
This document responds to growing need at country level for basic operational guidance on provider-initiated HIV testing and counseling in health facilities. It is intended for a wide audience including policy-makers, HIV/AIDS program planners and coordinators, health-care providers, non-governmental organizations providing HIV/AIDS services and civil society groups.
This publication is an update of the review of current knowledge on HIV transmission through breastfeeding, with a focus on information made available between 2001 and 2007. It reviews scientific evidence on the risk of HIV transmission through breastfeeding, the impact of different feeding options on child health outcomes, and conceivable strategies to reduce HIV transmission through breastfeeding with an emphasis on the developing world.
Care for HIV Positive Mothers and their Children and Families
Offering ongoing care and treatment and support for mothers with HIV and their infants helps to ensure the mother’s health and to protect the child’s health and development.
Effective treatment of pediatric HIV requires immediate diagnosis, early initiation of ART, and frequent monitoring. The updated (2010) WHO guidelines on antiretroviral therapy for infants and children are based on the most recent scientific research and reflect the most effective known regimens in a variety of clinical circumstances. Key highlights of the updated recommendations are summarized here.
This issue of Haba Na Haba Quarterly Technical Bulletin spotlights the care and treatment of HIV infection in infants and young children, specifically addressing early infant diagnosis, pediatric antiretroviral therpay, and steps to increasing early identification and treatment of infants and children living with HIV.
These guidelines offer a broad background on HIV and nutrition. Topics include malnutrition and HIV; micronutrients and mother-to-child transmission; nutrition, pregnancy and lactation; vitamin and mineral deficiencies; anemia, and iron supplementation and HIV; and nutrition and antiretroviral treatment. The guidelines also include recommendations covering nutrition assessment, nutrition counseling and support, use of micronutrient supplements, management of wasting, and nutritional considerations for persons on antiretroviral treatment.